Asia Pacific Biotechnology Market (2008-2012)

1. Analyst View

2. Global Biotechnology Industry Overview
     2.1 Market Overview
            2.1.1 Product Segmentation
            2.1.2 Geographical Segmentation

3. Asia-Pacific Biotechnology Market
     3.1 Market Overview
            3.1.1 Product Segmentation
            3.1.2 Geographical Segmentation
            3.1.3 Future Outlook (2010-2012)
     3.2 Key Market Drivers
            3.2.1 Strong Government Support
            3.2.2 Strong and Low Cost Human Resources
            3.2.3 Bio-diversity

4. Biotechnology Market by Country
     4.1 Japan
            4.1.1 Market Overview
            4.1.2 Product Segmentation
            4.1.3 Bio-clusters
            4.1.4 Success and Risk Factors
            4.1.5 Future Outlook (2010-2012)
     4.2 China
            4.2.1 Market Overview
            4.2.2 Product Segmentation
            4.2.3 Bio-clusters
            4.2.4 Success and Risk Factors
            4.2.5 Future Outlook (2010-2012)
     4.3 India
            4.3.1 Market Overview
            4.3.2 Product Segmentation
            4.3.3 Bio-clusters
            4.3.4 Success and Risk Factors
            4.3.5 Future Outlook (2010-11 to 2012-13)
     4.4 Australia
            4.4.1 Market Overview
            4.4.2 Bio-clusters
            4.4.3 Success and Risk Factors
            4.4.4 Future Outlook (2010-2012)
     4.5 Taiwan
            4.5.1 Market Overview
            4.5.2 Bio-clusters
            4.5.3 Success and Risk Factors
            4.5.4 Future Outlook (2010-2012)
     4.6 South Korea
            4.6.1 Market Overview
            4.6.2 Product Segmentation
            4.6.3 Bio-clusters
            4.6.4 Success and Risk Factors
            4.6.5 Future Outlook (2010-2012)
     4.7 New Zealand
            4.7.1 Market Overview
            4.7.2 Product Segmentation
            4.7.3 Success and Risk Factors
            4.7.4 Future Outlook (2010-2012)
     4.8 Singapore
            4.8.1 Market Overview
            4.8.2 Bio-clusters
            4.8.3 Success and Risk Factors
            4.8.4 Future Outlook (2010-2012)
     4.9 Malaysia
            4.9.1 Market Overview
            4.9.2 Success and Risk Factors
            4.9.3 Future Outlook (2010-2012)

5. Emerging Sectors
     5.1 Contract Research and Manufacturing
     5.2 Vaccines
     5.3 Generics
     5.4 Stem Cell Research
     5.5 Nanotechnology
     5.6 Bioinformatics

6. Roadblocks
     6.1 IPR Regime
     6.2 Private Participation
     6.3 Lack of Bioventures
     6.4 Inadequate Investment

7. Future Roadmap
     7.1 Government Support
     7.2 Role of Private Sector
     7.3 Mergers & Acquisitions
     7.4 Infrastructure Improvement

8. Competitive Landscape
     8.1 Invitrogen Corporation
     8.2 Takara Holdings, Inc.
     8.3 CSL Limited
     8.4 Biota Holdings Limited
     8.5 GlaxoSmithKline Plc